| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-04-17 |
股东大会：
将于2018-04-26召开股东大会
会议内容 ▼▲
- 1.The adoption and approval, pursuant to Section 320 of the Companies Law 5759-1999 of the State of Israel (the “Companies Law”), of the merger of Stone Marger Sub Ltd. (“Merger Sub”), a company incorporated under the laws of the State of Israel and a wholly owned subsidiary of Genoptix, Inc., a Delaware corporation (“Genoptix”), with and into the Company, including the adoption and approval of: (i) the Agreement and Plan of Merger, dated as of February 27, 2018 (the “Merger Agreement”), by and among Genoptix, Merger Sub, and the Company; (ii) the merger of Merger Sub with and into the Company (the “Merger”) on the terms and subject to the conditions set forth in the Merger Agreement and in accordance with Sections 314 through 327 of the Companies Law, following which the separate corporate existence of Merger Sub shall cease and the Company will become a private wholly-owned direct subsidiary of Genoptix; (iii) the consideration to be received by the shareholders of the Company in the Merger, preliminarily estimated to be $0.40 to $0.45 in cash, without interest and less any applicable withholding taxes, for each ordinary share of the Company, nominal (par) value NIS 7.2 per share, held immediately prior to the effective time of the Merger, with the exact price per ordinary share dependent on the final amounts of deductions and adjustments detailed in the Merger Agreement that have not yet been fixed, and the extent to which outstanding warrants are exercised and convertible debentures are converted prior to the effective time of the Merger; and (iv) all other transactions and arrangements contemplated by the Merger Agreement, including, without limitation, the purchase by the Company of a prepaid “tail” directors’ and officers’ liability insurance policy for a period of seven years following the effective time of the Merger.
|
| 2018-02-27 |
股东大会：
将于2018-04-06召开股东大会
会议内容 ▼▲
- 1.The adoption and approval, pursuant to Section 320 of the Companies Law 5759-1999 of the State of Israel (the “Companies Law”), of the merger of Stone Marger Sub Ltd. (“Merger Sub”), a company incorporated under the laws of the State of Israel and a wholly owned subsidiary of Genoptix, Inc., a Delaware corporation (“Genoptix”), with and into the Company, including the adoption and approval of: (i) the Agreement and Plan of Merger, dated as of February 27, 2018 (the “Merger Agreement”), by and among Genoptix, Merger Sub, and the Company; (ii) the merger of Merger Sub with and into the Company (the “Merger”) on the terms and subject to the conditions set forth in the Merger Agreement and in accordance with Sections 314 through 327 of the Companies Law, following which the separate corporate existence of Merger Sub shall cease and the Company will become a private wholly-owned direct subsidiary of Genoptix; (iii) the consideration to be received by the shareholders of the Company in the Merger, preliminarily estimated to be $0.40 to $0.45 in cash, without interest and less any applicable withholding taxes, for each ordinary share of the Company, nominal (par) value NIS 7.2 per share, held immediately prior to the effective time of the Merger, with the exact price per ordinary share dependent on the final amounts of deductions and adjustments detailed in the Merger Agreement that have not yet been fixed, and the extent to which outstanding warrants are exercised and convertible debentures are converted prior to the effective time of the Merger; and (iv) all other transactions and arrangements contemplated by the Merger Agreement, including, without limitation, the purchase by the Company of a prepaid “tail” directors’ and officers’ liability insurance policy for a period of seven years following the effective time of the Merger.
|
| 2018-02-15 |
股东大会：
将于2018-02-22召开股东大会
会议内容 ▼▲
- 1.The adoption and approval, pursuant to Section 320 of the Companies Law 5759-1999 of the State of Israel (the “Companies Law”), of the merger of the Company with and into Stone Marger Sub Ltd. (“Merger Sub”), a company incorporated under the laws of the State of Israel and a wholly owned subsidiary of Genoptix, Inc., a Delaware corporation (“Genoptix”), including the adoption and approval of: (i) the Agreement and Plan of Merger, dated as of December 14, 2017 (the “Merger Agreement”), by and among Genoptix, Merger Sub, and the Company; (ii) the merger of Merger Sub with and into the Company (the “Merger”) on the terms and subject to the conditions set forth in the Merger Agreement and in accordance with Sections 314 through 327 of the Companies Law, following which the separate corporate existence of Merger Sub shall cease and the Company shall become a private wholly-owned direct subsidiary of Genoptix; (iii) the consideration to be received by the shareholders of the Company in the Merger, preliminarily estimated to be $0.60 to $0.70 in cash, without interest and less any applicable withholding taxes, for each ordinary share of NIS 7.2 nominal (par) value held immediately prior to the effective time of the Merger, with the exact price per ordinary share dependent on the final amounts of deductions and adjustments detailed in the Merger Agreement that have not yet been fixed, and the extent to which outstanding warrants are exercised and convertible debentures are converted prior to the effective time of the Merger; and (iv) all other transactions and arrangements contemplated by the Merger Agreement, including, without limitation, the purchase by the Company of a “tail” prepaid directors’ and officers’ liability insurance policy for a period of seven years following the effective time of the Merger.
|
| 2017-12-28 |
详情>>
股本变动：
变动后总股本592.99万股
|
| 2017-12-15 |
复牌提示：
2017-12-15 08:56:54 停牌，复牌日期 2017-12-15 09:50:00
|
| 2017-12-06 |
股东大会：
将于2017-12-13召开股东大会
会议内容 ▼▲
- 1.Approval of the re-election of Mr. Brian A. Markison to serve as a Class I director of the Company for a three-year term commencing on the date of his election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2020 in accordance with the Company’s Articles of Association;
2.If Item 1 on the agenda of the Annual Meeting is approved, approval effective as of the date of the Annual Meeting, in accordance with Section 273(a) of the Israeli Companies Law, 5759-1999 (the “Companies Law”), of a grant to Mr. Brian A. Markison of (i) an option to purchase up to 2,000 of the Company’s ordinary shares, nominal (par) value NIS 7.2 each (“Ordinary Shares”) and (ii) 417 Restricted Stock Units (“RSUs”) upon the commencement of each twelve-month period in office as a director beginning on the date of the Annual Meeting;
3.Approval of the re-appointment of Kost, Forer, Gabbay & Kasierer, a member firm of Ernst & Young Global (“KFGK”), as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017, and until the next Annual Meeting, and to authorize the Audit committee and the Board of Directors of the Company to determine the remuneration of KFGK in accordance with the volume and nature of their services;
4.To discuss the Consolidated Financial Statements of the Company for the fiscal year ended December 31, 2016.
|
| 2017-09-18 |
股东大会：
将于2017-09-25召开股东大会
会议内容 ▼▲
- 1.To approve an increase of the Company’s registered (authorized) share capital and the corresponding amendment to the Company’s articles of associations (the “Articles”), all as described in the accompanying proxy statement.
2.If Item 1 on the agenda of the Extraordinary Meeting is approved, approval of an addition of 255,840 ordinary shares, nominal (par) value NIS 7.2 each (“Ordinary Shares”), to the shares authorized for issuance under the Company’s 2006 Employee Incentive Plan (Global Share Incentive Plan (2006)) (“GSIP”), so that the total number of Ordinary Shares authorized for issuance under the GSIP will equal 450,000.
|
| 2017-03-30 |
详情>>
业绩披露：
2016年年报每股收益-9.31美元,归母净利润-1623.3万美元,同比去年增长6.41%
|
| 2017-03-16 |
详情>>
拆分方案：
每12.0000合并分成1.0000股
|
| 2017-02-03 |
股东大会：
将于2017-03-16召开股东大会
会议内容 ▼▲
- 1. To approve the consolidation of the Company’s ordinary shares into a smaller number of shares with a greater nominal (par) value per share and the corresponding amendment to the Company’s articles of association (the “Articles”), all as described in the accompanying proxy statement;
2. To approve an increase of the Company’s registered (authorized) share capital and the corresponding amendment to the Articles, all as described in the accompanying proxy statement
|
| 2016-06-24 |
股东大会：
将于2016-08-08召开股东大会
会议内容 ▼▲
- 1. Approval of the re-election of Mr. Roy Davis to serve as a Class III director of the Company for a three year term commencing on the date of his election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2019 in accordance with the Company’s Articles of Association
2. If Item 1 on the agenda of the Annual Meeting is approved, approval effective as of the date of the Annual Meeting, in accordance with Section 273(a) of the Israeli Companies Law, 5759-1999 (the “Companies Law”), of a grant to Mr. Roy Davis of an option to purchase up to 24,000 of the Company’s ordinary shares, nominal (par) value NIS 0.6 each (“Ordinary Shares”)
3. Approval of the re-election of Mr. Gerald Dogon to serve as a Class III director of the Company for a three year term commencing on the date of his election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2019 in accordance with the Company’s Articles of Association
4. If Item 3 on the agenda of the Annual Meeting is approved, approval effective as of the date of the Annual Meeting, in accordance with Section 273(a) of the Companies Law, of a grant to Mr. Gerald Dogon of an option to purchase up to 24,000 Ordinary Shares
5. Approval of the re-election of Ms. Tali Yaron-Eldar to serve as a Class III director of the Company for a three year term commencing on the date of her election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2019 in accordance with the Company’s Articles of Association
6. If Item 5 on the agenda of the Annual Meeting is approved, approval effective as of the date of the Annual Meeting, in accordance with Section 273(a) of the Companies Law of a grant to Ms. Tali Yaron-Eldar of an option to purchase up to 24,000 Ordinary Shares
7. Approval effective as of the date of the Annual Meeting, in accordance with Section 273(a) of the Companies Law, of a grant to Mr. Joshua Rosensweig, a director of the Company, of an option to purchase up to 24,000 Ordinary Shares
8. Approval of a compensation policy for the Company’s directors and officers, in accordance with the requirements of the Companies Law
9. Approval of an update to the remuneration for the chairs of committees of the Board of Directors of the Company
10. Approval of the re-appointment of Kost, Forer, Gabbay & Kasierer, a member firm of Ernst & Young Global (“KFGK”), as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2016, and until the next Annual Meeting, and to authorize the Audit committee and the Board of Directors of the Company to determine the remuneration of KFGK in accordance with the volume and nature of their services
11. To discuss the Consolidated Financial Statements of the Company for the fiscal year ended December 31, 2015.
|
| 2016-03-23 |
详情>>
业绩披露：
2015年年报每股收益-1.15美元,归母净利润-1734.5万美元,同比去年增长-19.41%
|
| 2015-10-27 |
股东大会：
将于2015-12-03召开股东大会
会议内容 ▼▲
- 1.RE-ELECTION OF DR. DAVID SIDRANSKY AND HIS REMUNERATION AS A DIRECTOR
2.CONDITIONAL GRANT OF OPTIONS TO DR. DAVID SIDRANSKY
3.RE-ELECTION OF MR. JOSHUA ROSENSWEIG
4.APPROVAL OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM AND AUTHORIZATION TO DETERMINE COMPENSATION
5.INCREASE OF THE NUMBER OF ORDINARY SHARES AVAILABLE FOR ISSUANCE UNDER THE COMPANY’S GLOBAL SHARE INCENTIVE PLAN
6.TO APPROVE THE EXTENSION OF THE TERMS OF EMPLOYMENT OF MR. KEN BERLIN AND AMENDMENT TO HIS BONUS ENTITLEMENT AND DEFINITION OF CHANGE OF CONTROL IN HIS AGREEMENT
7.APPROVAL OF GRANT OF OPTION AND RESTRICTED STOCK UNITS TO MR. KEN BERLIN, THE CHIEF EXECUTIVE OFFICER OF THE COMPANY
8.INCREASE OF SHARE CAPITAL
|
| 2015-03-16 |
详情>>
业绩披露：
2014年年报每股收益-1.29美元,归母净利润-1452.6万美元,同比去年增长-12.63%
|
| 2014-10-15 |
股东大会：
将于2014-11-05召开股东大会
会议内容 ▼▲
- 1. Approval of the re-election of Mr. Brian A. Markison to serve as a Class I director of the Company for a 3 year term commencing on the date of his election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2017 in accordance with the Company’s Articles of Association;
2. Approval of the re-election of Dr. Yitzhak Peterburg to serve as a Class I director of the Company for a 3 year term commencing on the date of his election at the Annual Meeting and until the Annual General Meeting of the Company’s shareholders to be held in 2017 in accordance with the Company’s Articles of Association;
3. Approval of the re-appointment of Kost, Forer, Gabbay & Kasierer, a member firm of Ernst & Young Global (“KFGK”), as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2014, and until the next Annual Meeting, and to authorize the Audit committee and the Board of Directors of the Company to determine the remuneration of KFGK in accordance with the volume and nature of their services;
4. Approval of the addition of 900,000 ordinary shares, nominal (par) value NIS 0.6 each (“Ordinary Shares”), to the shares authorized for issuance under the Company’s 2006 Employee Incentive Plan (Global Share Incentive Plan (2006)) (“GSIP”), so that the total number of Ordinary Shares authorized for issuance under the GSIP will equal 1,803,739;
5. Approval effective as of January 1, 2014, in accordance with Section 272(c1)(1) of the Israeli Companies, Law, 5759-1999 (the “Companies Law”) of an extension, to the amendment dated June 3, 2012 of the employment agreement of Mr. Ken Berlin, the Chief Executive Officer of the Company. According to such amendment, the CEO is entitled to a base salary at the annual rate of $500,000 USD, payable bi-weekly or otherwise in accordance with the payroll policy of the Company, set to expire at the Company’s 2015 Annual Shareholder Meeting;
6. Approval, in accordance with Section 272(c1)(1) of the Companies, Law, for Mr. Ken Berlin, the Chief Executive Officer of the Company, of a grant of options to purchase up to 100,000 Ordinary Shares of the Company at an exercise price per share equal to the closing price on November 30, 2014, vesting in equal installments quarterly over a period of four (4) years beginning on November 30, 2014, and such options shall expire seven (7) years after their date of grant, unless they expire earlier in accordance with the terms of the GSIP and 20,000 Restricted Stock Units (“RSUs”) vesting in equal installments annually over a period of four (4) years beginning on November 30, 2014. The options and RSUs are granted and otherwise subject to the same terms and conditions as applicable to options and RSUs granted under the GSIP.
7. Replacement of Section 38 of the Company’s Articles of Association with the following: “The Board of Directors of the Company shall consist of not less than two (2) nor more than seven (7) Directors”;
8. To discuss the Consolidated Financial Statements of the Company for the fiscal year ended December 31, 2013.
|
| 2014-03-31 |
详情>>
业绩披露：
2013年年报每股收益-1.34美元,归母净利润-1289.7万美元,同比去年增长-23.33%
|
| 2013-06-21 |
股东大会：
将于2013-07-29召开股东大会
会议内容 ▼▲
- 1. Re-election of Mr. Roy N. Davis to serve as a Class III director of the Company until the annual general meeting of the Company’s shareholders to be held in 2016 in accordance with the Company’s Articles of Association;
2. To approve an update to the remuneration of the directors of the Company;
3. Re-election of Mr. Gerald Dogon to serve as external director of the Company for an additional period of three years beginning on the date of approval by the Annual Meeting;
4. Re-election of Ms. Tali Yaron-Eldar to serve as external director of the Company for an additional period of three years beginning on the date of approval by the Annual Meeting;
5. Approval of remuneration for the external directors;
6. Approval of a compensation policy for the Company’s directors and officers, in accordance with the requirements of the Israeli Companies Law, 1999;
7. Approval of an option grant to Mr. Ken Berlin, the Chief Executive Officer of the Company;
8. Approval of an increase of the Company’s registered (authorized) share capital and the corresponding amendment to the Articles, all as described in the accompanying proxy statement;
9. Re-appointment of Kost, Forer, Gabbay & Kasierer, a member firm of Ernst & Young Global (“KFGK”), as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2013, and until the next annual general meeting, and to authorize the Board to determine the remuneration of KFGK in accordance with the volume and nature of their services, provided such remuneration is also approved by the Audit Committee of the Board of Directors;
10. To discuss the report of the independent registered public accounting firm and the Consolidated Financial Statements of the Company for the fiscal year ended December 31, 2012.
|
| 2013-03-22 |
详情>>
业绩披露：
2012年年报每股收益-2.35美元,归母净利润-1045.7万美元,同比去年增长-18.43%
|
| 2012-04-02 |
详情>>
业绩披露：
2011年年报每股收益-1.16美元,归母净利润-883万美元,同比去年增长40.16%
|
| 2011-03-31 |
详情>>
业绩披露：
2010年年报每股收益-0.87美元,归母净利润-1475.5万美元,同比去年增长10.60%
|